PETV logo

PetVivo Holdings, Inc. Stock Price

OTCPK:PETV Community·US$36.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PETV Share Price Performance

US$1.30
0.70 (116.67%)
US$1.30
0.70 (116.67%)
Price US$1.30

PETV Community Narratives

There are no narratives available yet.

Recent PETV News & Updates

PetVivo Holdings, Inc. Key Details

US$1.3m

Revenue

US$235.5k

Cost of Revenue

US$1.1m

Gross Profit

US$9.8m

Other Expenses

-US$8.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.30
Gross Margin
81.98%
Net Profit Margin
-665.38%
Debt/Equity Ratio
39.3%

PetVivo Holdings, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

About PETV

Founded
n/a
Employees
24
CEO
John Lai
WebsiteView website
www.petvivo.com

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company’s lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.4%
  • 3 Months: 7.8%
  • 1 Year: 17.8%
  • Year to Date: 14.7%
The Healthcare sector gained 3.7% while the market remained flat over the last week. More promisingly, the market is up 18% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›